New study highlights urgent need for specific biomarkers in vascular cognitive impairment and dementia diagnosis … $3.9 million NIH grant supports research on effects of integrated palliative care on...
Clinical briefs for Friday, July 21
By
Kristen Fischer
Jul 21, 2023
CMS proposes nixing PET scan limits, which could make it easier to access Leqembi … Here’s how diabetes impairs eye healing … Semaglutide diabetes med safe in adults over 55 … Be patient if you...
Clinical briefs for Tuesday, Nov. 22
By
Alicia Lasek
Nov 22, 2022
FDA: Philips recalls some previously replaced Trilogy ventilators … Anti-hyperglycemic drugs raise risk of MS in patients with diabetes … NIH awards $12M for developing antivirals against viruses...
Researchers: Drop 13% body weight to drop type 2 diabetes risk by 40%
By
Kimberly Marselas
Sep 10, 2020
An average loss of 13% of total body weight reduces the risk of developing type 2 diabetes by around 40% in obese individuals, researchers told the European and International Congress on Obesity.
CMS names 10 drugs slated for Medicare price negotiation
By
John Roszkowski
Aug 30, 2023
The Biden administration announced Tuesday the first 10 prescription drugs that would be selected for negotiation under the Medicare Drug Price Negotiation Program designed to lower the costs of prescription...
Most US adults with type 2 diabetes meet criteria for GLP-RAs, SGLT2is
Feb 28, 2023
More than 82% US adults with type 2 diabetes meet the criteria to be prescribed the drugs, yet only 9% use either of them.
Diabetes indicators improve with use of health incentives, CDC study finds
By
Alicia Lasek
Nov 10, 2022
Incentivizing patients to follow a lifestyle modification program helps them to improve a full range of diabetes-related health measures, according to a new meta-analysis.